Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis
A completed clinical trial evaluating adverse events and changes in disease symptoms in Korean participants with rheumatoid arthritis, atopi…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Study of Guselkumab in Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial update for guselkumab in active psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Study of Guselkumab in Participants With Active Psoriatic Arthritis [Phase 3]
Guselkumab is being studied in a Phase 3 trial for active psoriatic arthritis. The study is currently active but not recruiting, and results…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Upadacitinib Versus IL-17 Inhibitors in Patients With Psoriatic Arthritis
A completed clinical trial comparing upadacitinib with IL-17 inhibitors in patients with psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight [Phase 3]
Phase 3 trial evaluating the concomitant use of ixekizumab and tirzepatide in adults with psoriatic arthritis who are obese or overweight; t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) [Phase 3]
Clinical trial update evaluating the efficacy and safety of tildrakizumab versus placebo in active psoriatic arthritis in a Phase 3 study (I…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients [NA]
This clinical trial update notes that the study assessing fatigue in patients with psoriatic arthritis and cutaneous psoriasis has completed…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis [NA]
A completed clinical trial update from Surf Therapeutics examining activation of the cholinergic anti-inflammatory pathway in healthy volunt…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects [Phase 1]
A Phase 1 study comparing pharmacokinetics and safety of Celltrion's CT-P52 against US-licensed ixekizumab (Taltz) in healthy participants.
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent [Phase 3]
Phase 3 results for guselkumab in active psoriatic arthritis patients who had inadequate response or intolerance to one prior anti-TNF agent…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent [Phase 3]
Phase 3 trial update evaluating guselkumab in active psoriatic arthritis patients with inadequate response/intolerance to one prior anti-TNF…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
A post-marketing safety study in Denmark evaluated abatacept (Orencia) for rheumatoid arthritis and psoriatic arthritis; the study has compl…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
A post-marketing safety study of abatacept in Sweden using the SRQ register has completed, evaluating safety in rheumatoid arthritis and pso…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA [Phase 3]
Phase 3 trial comparing golimumab plus methotrexate against methotrexate alone in very early psoriatic arthritis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial [Phase 4]
The SPEED trial, a Phase 4 study of early intervention to control disease in severe psoriatic arthritis, has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Effect of Metformin on Carotid Atherosclerosis for Non-diabetic Patients With PsA (CAMPA Study) [Phase 4]
Phase 4 trial evaluating whether metformin affects carotid atherosclerosis in non-diabetic patients with psoriatic arthritis; the CAMPA stud…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis [Phase 1]
Phase 1 clinical trial assessing the safety and pharmacokinetics of LPX-TI641 in patients with rheumatoid arthritis and psoriatic arthritis,…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: The Effect of Ketogenic Diet Versus Mediterranean Diet in Patients With Obesity and Psoriatic Arthritis [NA]
Completed clinical trial comparing ketogenic diet to Mediterranean diet in adults with obesity and psoriatic arthritis; the available snippe…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs [Phase 3]
Phase 3 study comparing deucravacitinib to placebo in biologic disease-modifying anti-rheumatic drug-naïve patients with active psoriatic ar…
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment [Phase 3]
Phase 3 trial comparing secukinumab with ustekinumab in adults with active psoriatic arthritis after TNFα-inhibitor failure has completed an…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice
Pfizer-sponsored clinical trial update shows real-world effectiveness of tofacitinib for psoriatic arthritis in routine clinical practice. R…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic Diseases [NA]
Clinical trial update on a high-touch, low-cost approach to improving mental health outcomes in patients with psoriatic diseases; the study …
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions
A clinical trial update reports on the use of apremilast in patients with psoriatic arthritis under practice-like conditions. The study NCT0…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Follow-up Evaluating Clinical and Radiological Outcomes of Total Shoulder Arthroplasty With Permedica's MIRAI Prosthesis
Follow-up results from a completed clinical trial assessing the MIRAI total shoulder prosthesis, reporting clinical and radiological outcome…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India [Phase 4]
A Phase 4 study evaluating ixekizumab for adults with plaque psoriasis or psoriatic arthritis in India has completed, with results posted.